Clinical Trials/NCT01788592

NCT01788592

Recruiting

N/A

Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice

Seung-Jung Park1 site in 1 country50,000 target enrollmentJanuary 1, 2003

ConditionsCoronary Artery Disease

Overview

Phase: N/A
Intervention: Not specified
Conditions: Coronary Artery Disease
Sponsor: Seung-Jung Park
Enrollment: 50000
Locations: 1
Primary Endpoint: Major Adverse Cardiac Event
Status: Recruiting
Last Updated: 4 months ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The objective of this study is to evaluate effectiveness and safety of drug-eluting stent implantation in the "real world" daily practice.

Registry

clinicaltrials.gov

Start Date

January 1, 2003

End Date

October 1, 2030

Last Updated

4 months ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Seung-Jung Park

Responsible Party

Sponsor Investigator

Principal Investigator

Seung-Jung Park

MD,PhD, Chairman,Heart Institute, Asan Medical Center,University of Ulsan,College of Medicine

Asan Medical Center

Eligibility Criteria

Inclusion Criteria

•coronary disease amenable to percutaneous coronary intervention (PCI)
•no clinical and lesion limitations

Exclusion Criteria

•patients with a mixture of several drug eluting stents
•terminal illness with life expectancy less than 1 year
•patients with cardiogenic shock

Outcomes

Primary Outcomes

Major Adverse Cardiac Event

Time Frame: 1year

Death from any causes, myocardial infarction or any repeat revascularization

Secondary Outcomes

Stent thrombosis by Academic Research Consortium criteria(1year)
Myocardial Infarction(1year)
Target vessel revascularization(1year)
all cause Death(1year)
The composite of Death or myocardial infarction(1year)
New lesion revascularization(1year)
Target lesion revascularization(1year)
Any repeat revascularization(1year)

Study Sites (1)

Loading locations...

Similar Trials

Recruiting

N/A

Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical PracticeCoronary Artery DiseasePercutaneous Transluminal Coronary Angioplasty

NCT01186133Seung-Jung Park50,000

Completed

Phase 4

Efficacy Study of Drug-eluting and Bare Metal Stents in Bypass Graft LesionsArteriosclerosis of Arterial Coronary Artery Bypass Graft

NCT00611910Deutsches Herzzentrum Muenchen610

Terminated

Phase 4

Drug-Eluting Stent Implantation Versus Optimal Medical Treatment in Patients With Chronic Total Occlusion (DECISION-CTO)Coronary Artery Disease

NCT01078051Seung-Jung Park840

Completed

N/A

Evaluating the Safety and Efficacy of the Maurora® DES in ICASIntracranial ArteriosclerosisStroke (CVA) or TIA

NCT05719883Beijing Tiantan Hospital156

Unknown

N/A

Retrospective Study of the Impact of Drug Eluting StentsCoronary Artery Disease

NCT00487604Providence Health & Services9,800